A. Thompson

6.5k total citations
75 papers, 2.2k citations indexed

About

A. Thompson is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, A. Thompson has authored 75 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hepatology, 60 papers in Epidemiology and 9 papers in Rheumatology. Recurrent topics in A. Thompson's work include Hepatitis C virus research (55 papers), Liver Disease Diagnosis and Treatment (44 papers) and Hepatitis B Virus Studies (42 papers). A. Thompson is often cited by papers focused on Hepatitis C virus research (55 papers), Liver Disease Diagnosis and Treatment (44 papers) and Hepatitis B Virus Studies (42 papers). A. Thompson collaborates with scholars based in Australia, United States and New Zealand. A. Thompson's co-authors include Stephen Locarnini, John G. McHutchison, Paul Desmond, Kumar Visvanathan, Paul J. Clark, Teerha Piratvisuth, Sharon R. Lewin, Hans L. Tillmann, Narelle Skinner and Jidong Jia and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

A. Thompson

74 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Thompson Australia	24	1.7k	1.6k	379	344	171	75	2.2k
Thomas Vanwolleghem Belgium	23	1.9k 1.1×	1.7k 1.1×	392 1.0×	407 1.2×	229 1.3×	84	2.5k
Geoffrey Dusheiko United Kingdom	18	1.8k 1.1×	1.7k 1.1×	444 1.2×	418 1.2×	150 0.9×	33	2.2k
Qing Mao China	24	1.2k 0.7×	1.2k 0.8×	298 0.8×	190 0.6×	185 1.1×	72	1.7k
Sanaa M. Kamal Egypt	24	1.6k 0.9×	1.8k 1.1×	192 0.5×	198 0.6×	123 0.7×	60	2.4k
Stéphane Chevaliez France	35	2.9k 1.7×	2.9k 1.8×	205 0.5×	831 2.4×	277 1.6×	144	3.6k
Gaia Nebbia United Kingdom	20	1.2k 0.7×	716 0.4×	710 1.9×	432 1.3×	125 0.7×	47	1.9k
Khayriyyah Mohd Hanafiah Malaysia	8	1.6k 0.9×	1.8k 1.1×	84 0.2×	323 0.9×	168 1.0×	20	2.2k
Phillip S. Pang United States	27	2.0k 1.2×	2.2k 1.4×	88 0.2×	679 2.0×	284 1.7×	55	2.8k
G. L. Toms United Kingdom	24	1.4k 0.8×	643 0.4×	185 0.5×	522 1.5×	149 0.9×	79	1.9k
Susan McKiernan Ireland	16	704 0.4×	907 0.6×	450 1.2×	135 0.4×	78 0.5×	49	1.4k

Countries citing papers authored by A. Thompson

Since Specialization

Citations

This map shows the geographic impact of A. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Thompson more than expected).

Fields of papers citing papers by A. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Thompson. The network helps show where A. Thompson may publish in the future.

Co-authorship network of co-authors of A. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of A. Thompson. A scholar is included among the top collaborators of A. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Thompson. A. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Griffin, S., Shelley Walker, Jacinta A. Holmes, et al.. (2025). "Quick, simple, and friendly": Understanding the acceptability and accessibility of a nurse and peer-led, mobile model of hepatitis C care adjacent to community corrections in Australia. International Journal of Drug Policy. 139. 104785–104785. 1 indexed citations

Wallace, Jack, Yinzong Xiao, Jess Howell, et al.. (2022). Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia. BMC Public Health. 22(1). 536–536. 3 indexed citations

Labbé, Delphine, et al.. (2020). All aboard: users’ experiences of adapted paddling programs. Disability and Rehabilitation. 43(20). 2945–2951. 10 indexed citations

Thompson, A., Edward G. Johnson, Matthew D. Edmonds, et al.. (2020). Effect of Direct-Fed Microbial Supplementation on Pathogenic <i>Escherichia coli</i> Fecal Shedding, Live Performance, and Carcass Characteristics in Feedlot Steers. Open Journal of Animal Sciences. 10(4). 683–705. 2 indexed citations

New, Karen, Sean C. Glasgow, Catherine Croagh, et al.. (2019). Eliminating hepatitis C by 2030: Hospital presentation provides opportunities for engagement and treatment of marginalized individuals with chronic hepatitis C. Journal of Gastroenterology and Hepatology. 34. 1 indexed citations

Chan, Henry Lik‐Yuen, Diethelm Messinger, George Papatheodoridis, et al.. (2018). A baseline tool for predicting response to peginterferon alfa‐2a in HBeAg‐positive patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics. 48(5). 547–555. 22 indexed citations

Bourlière, Marc, Stuart C. Gordon, Eugene R. Schiff, et al.. (2018). Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1. The Lancet. Gastroenterology & hepatology. 3(8). 559–565. 18 indexed citations

Wade, Amanda, Joseph Doyle, Edward Gane, et al.. (2018). Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial. Trials. 19(1). 383–383. 6 indexed citations

Younossi, Zobair M., Maria Stepanova, Ira M. Jacobson, et al.. (2017). Sofosbuvir and velpatasvir with or without voxilaprevir in direct‐acting antiviral‐naïve chronic hepatitis C: patient‐reported outcomes from POLARIS 2 and 3. Alimentary Pharmacology & Therapeutics. 47(2). 259–267. 34 indexed citations

10.

McCaughan, Geoffrey W., Stuart K. Roberts, Simone I. Strasser, et al.. (2017). Sofosbuvir and daclatasvir therapy in patients with hepatitis C‐related advanced decompensated liver disease (MELD ≥ 15). Alimentary Pharmacology & Therapeutics. 47(3). 401–411. 12 indexed citations

11.

Hellard, Margaret, Emma S. McBryde, Rachel Sacks‐Davis, et al.. (2015). Hepatitis C transmission and treatment as prevention – The role of the injecting network. International Journal of Drug Policy. 26(10). 958–962. 54 indexed citations

12.

Thompson, A., Scott Devine, Michael W. Kattan, & Andrew J. Muir. (2014). Prediction of Treatment Week Eight Response & Sustained Virologic Response in Patients Treated with Boceprevir Plus Peginterferon Alfa and Ribavirin. PLoS ONE. 9(8). e103370–e103370. 4 indexed citations

13.

Veldt, Bart J., Andrés Duarte‐Rojo, A. Thompson, et al.. (2012). Recipient IL28B Polymorphism Is an Important Independent Predictor of Posttransplant Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C. American Journal of Transplantation. 12(3). 737–744. 22 indexed citations

14.

Gellad, Ziad F., Susanna Naggie, Shelby D. Reed, et al.. (2011). The Cost-Effectiveness of a Telaprevir-Inclusive Regimen as Initial Therapy for Genotype 1 Hepatitis C Infection in Individuals with the Cc Il-28B Polymorphism. Hepatology. 54. 13 indexed citations

15.

Lao, Xiang Qian, A. Thompson, John G. McHutchison, & Jeanette McCarthy. (2010). Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys. Journal of Viral Hepatitis. 18(8). 571–579. 20 indexed citations

16.

Thompson, A. & John G. McHutchison. (2009). Review article: investigational agents for chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 29(7). 689–705. 25 indexed citations

17.

Thompson, A., et al.. (2008). Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges. Journal of Hepatology. 50(1). 184–194. 49 indexed citations

18.

Bowden, D. Scott & A. Thompson. (2008). New developments in HBV molecular diagnostics and quantitative serology. Hepatology International. 2(S1). 3–11. 9 indexed citations

19.

Visvanathan, Kumar, Narelle Skinner, A. Thompson, et al.. (2006). Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology. 45(1). 102–110. 276 indexed citations

20.

Bell, Sally, Audrey Lau, A. Thompson, et al.. (2004). Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients. Journal of Clinical Virology. 32(2). 122–127. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact